The company had a healthy cash balance of $4.72 million at the end of the quarter.
Showing 25 of 1912
Last month, Edison increased their valuation for Regeneus to 87 cents per share.
Canadian subsidiary Crystal Mountain is expanding its range of hydroponics equipment to meet expected demand.
The medical cannabis company is vertically integrated from 'farm to pharma'.
There were no adverse safety findings and excellent drug-like properties were confirmed.
A strategic review will see more focus on the largest global markets for medicinal cannabis.
Fifteen patients have been enrolled in the trial being carried out at Children’s Hospital of Philadelphia in the USA.
New skincare formulations are to be developed with Affinity’s algae and cannabis oils.
The online education resources aim to bring awareness to medical professionals.
The companies will collaborate on activities to develop cannabinoid medicines as a medical option in Chile.
The company’s shares are trading about 121% higher intra-day, at 4.2 cents.
AusCann is transitioning from a start-up company focused on product development to a pharmaceutical production and sales business.
The study is being led by one of Australia’s leading sleep research centres.
Patients can access the company's drug through the TGA special access scheme.
Discovered a compound that is a potent inhibitor of IRAK4 protein which causes chronic inflammation including autoimmune diseases.
CannPal plans to take the results from its recently commenced phase 1A and B studies to file an Investigational New Animal Drug application with the FDA.
KEY-Vaxx has shown potential in preclinical studies, outperforming an industry-standard antibody.
The company's revenue increased $120.0 million to $879.0million in FY2018.
Shares of the health sciences company soar sharply in both Canada and New York
Ed Rayner is an investment director for major shareholder Arix Bioscience Plc (LSE:ARIX).
The company is utilising technology and big data to tackle the growing healthcare crisis and personalise treatment options for preventative care.
The milk will be promoted on China’s JiaJia TV shopping channel which has 385 million viewers.
The company sells clinically validated anti-ageing products for hair, skin and body.
The company recommenced trading today up 13.3% to 3.4 cents per share.
The company aims to release its first medicinal cannabis products in FY2019.